Literature DB >> 18521212

Should cancer survivors fear radiation-induced sarcomas?

M Feigen1.   

Abstract

Entities:  

Year:  1997        PMID： 18521212      PMCID： PMC2395353          DOI： 10.1080/13577149778407

Source DB:  PubMed          Journal:  Sarcoma        ISSN： 1357-714X


× No keyword cloud information.
  7 in total

1.  Radiotherapy-induced second cancers: are we doing enough to protect young patients?

Authors:  R Epstein; I Hanham; R Dale
Journal:  Eur J Cancer       Date:  1997-04       Impact factor: 9.162

2.  Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer.

Authors:  S M Pierce; A Recht; T I Lingos; A Abner; F Vicini; B Silver; A Herzog; J R Harris
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

3.  The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique.

Authors:  A Tinger; T H Wasserman; E E Klein; E A Miller; T Roberts; J V Piephoff; N A Kucik
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-03-01       Impact factor: 7.038

4.  Active minimisation of radiation scatter during breast radiotherapy: management implications for young patients with good-prognosis primary neoplasms.

Authors:  R J Epstein; S A Kelly; M Cook; A Bateman; I Paddick; K C Kam; P Dunn; I W Hanham; R G Dale; P M Price
Journal:  Radiother Oncol       Date:  1996-07       Impact factor: 6.280

5.  Soft tissue sarcoma after treatment for breast cancer.

Authors:  P Karlsson; E Holmberg; K A Johansson; L G Kindblom; J Carstensen; A Wallgren
Journal:  Radiother Oncol       Date:  1996-01       Impact factor: 6.280

6.  Breast cancer after treatment of Hodgkin's disease.

Authors:  S L Hancock; M A Tucker; R T Hoppe
Journal:  J Natl Cancer Inst       Date:  1993-01-06       Impact factor: 13.506

7.  Should cancer survivors fear radiation-induced sarcomas?

Authors:  M Feigen
Journal:  Sarcoma       Date:  1997
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.